Martina Imbimbo - Concepedia

Author

Martina Imbimbo

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

Imbimbo, Martina, M. Imbimbo, Martina Imbimbo

171

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Mario Negri Institute for Pharmacological Research Istituti di Ricovero e Cura a Carattere Scientifico Humanitas University

About

Martina Imbimbo is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	569
2	Health Sciences	3	3	61
3	Nursing	1	1	63
4	Cell Biology	1	1	36
5	Endocrinology	1	1	26

Martina Imbimbo

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors Giovanni Fucà, Giulia Galli, M. Poggi, ESMO Open	2019	203
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab, European Journal of Cancer	2021	180
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact Laura D. Locati, Federica Perrone, Barbara Cortelazzi, European Journal of Cancer Surgical OncologyMedicinePathologyPhase Ii StudyHead And Neck Cancer	2016	99
Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer Giulia Galli, Tiziana Triulzi, Claudia Proto, Lung Cancer AntibioticsMedicineImmunologyAntimicrobial ResistanceAntimicrobial Chemotherapy	2019	73
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 <sup>+</sup> T-myeloid cell networks in melanoma David Barras, Eleonora Ghisoni, Johanna Chiffelle, Science Immunology	2024	71
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy Paolo Bossi, Cristiana Bergamini, Rosalba Miceli, International Journal of Radiation OncologyBiologyPhysics Salivary Cytokine LevelsRadiation TherapyMedicineOral CavityImmunology	2016	69
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? Cristiana Bergamini, Laura D. Locati, Paolo Bossi, Oral Oncology NursingPrimary CareSurgical OncologyOncologyNeck Cancer	2016	63
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study Yvette Drew, Jae‐Weon Kim, Richard T. Penson, Clinical Cancer Research	2023	59
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) Martina Imbimbo, Margaret Ottaviano, Milena Vitali, Cancer Treatment Reviews Surgical OncologyMedicineThyroid DiseasePathologyThymic Epithelial Tumors	2018	55
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow‐up Martina Imbimbo, Salvatore Alfieri, Laura Botta, Otolaryngology	2019	37

Page 1